Corrigendum: NLRP3 Overexpression Associated With Poor Prognosis and Presented as an Effective Therapeutic Target in Osteosarcoma

Front Pharmacol. 2021 Sep 2:12:753231. doi: 10.3389/fphar.2021.753231. eCollection 2021.

Zhen Huang^{1

2

3}, Hui Chen⁴, Shenglin Wang³, Hongxiang Wei³, Xinwen Wang⁵, Rongkai Shen³, Yunqing Wang³, Rongjin Lin⁶, Jianhua Lin^{2

3}

¹ Department of Rehabilitation, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
² Department of Orthopedics, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
³ Fujian Orthopedics Research Institution, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
⁴ Department of Nephrology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
⁵ Department of Orthopedics, The People's Hospital of Jiangmen City, Southern Medical University, Jiangmen, China.
⁶ Department of Nursing, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.

Abstract

[This corrects the article DOI: 10.3389/fphar.2021.724923.].

Keywords: CY-09; NLRP3; lentivirus; osteosarcoma; prognosis.